Enhancing Patient-Centered Decision-Making: Quinte...
In efforts to push for the use of registry data to support patient-centered decision-making in regulatory and health technology assessment (HTA) pr...
In efforts to push for the use of registry data to support patient-centered decision-making in regulatory and health technology assessment (HTA) pr...
Quinten Health joins ISPOR Europe 2023, the leading European conference for health economics and outcomes research (HEOR) in Copenhagen.We're...
Quinten Health is proud to announce that it has received the "Top 5% Poster" award at the 2023 ISPOR conference ! This distinction was awarded to...
Quinten Health will be at ISPOR Annual 2023 in Boston!On May 7-10, Quinten Health will be at the at ISPOR 2023 in Boston ! We will present 3...
Quinten Health will be at ISPOR Europe 2022 in Vienna.Billy Amzal (CEO) will be at ISPOR Europe 2022 from Nov. 6th to Nov. 9th 2022 in Vienna,...
This study aimed to evaluate renal function preservation (RFP) of SGLT2i vs DPP4i in Japanese type 2 diabetes patients and identify patient sub-gro...